Intuitive Health Monitoring. Unprecedented Simplicity.

Innovating Patient-Centered Blood Collection and Analysis

Seventh Sense - Overcoming Barriers to Successful Blood Sample Collection

With its proprietary TAP Touch Activated Phlebotomy™ blood sampling technology, Seventh Sense is improving ease-of-use and providing a less painful method of blood collection across many care settings.

Seventh Sense Lead Product: TAP20C™ Blood Collection Device™

Seventh Sense's first marketed product will collect up to 20 micro liters of blood, enough for many common tests. With virtually pain-free blood collection, the diagnostic process will be made easier for both patients and clinicians.

Company News

  • October 24, 2013 Seventh Sense BioSystems Receives CE Mark Approval for its Touch Activated Phlebotomy Blood Collection and Testing System
  • April 2, 2013 – Seventh Sense Biosystems Announces Initiation of Registration Trial for Virtually Painless TAP™ Blood Collection Device
  • July 12, 2012 – Seventh Sense's TAP virtually painless blood collection technology featured on WBZ News
  • June 13, 2012 – Howard Weisman joins Seventh Sense Biosystems as Chief Executive Officer and President, Company completes $10 million Series-A financing
  • December 16, 2011 – Seventh Sense Biosystems Receives $3.28 Million Grand Challenges Grant to Expand TAP Touch Activated Phlebotomy™
  • 20111 Edison AwardApril 8, 2011 Seventh Sense Biosystems' TAP blood access technology wins gold medal at 2011 Edison Awards

Products presented in this website are not available for sale or distribution and are limited to clinical investigational use only.
© Seventh Sense Biosystems, Inc.  |  286 Cardinal Medeiros Avenue, Cambridge, MA 02141  |  Phone: 617-547-SBIO  |  Fax: 617-547-0770  |  Email:  |  Privacy Policy
Web site designed and developed by RainCastle Communications, Inc.